subscribeSubscribe
price-trendAsk Us
Gossamer Bio`s DP2 inhibitor GB001 fails 2 midphase trials

Gossamer Bio`s DP2 inhibitor GB001 fails 2 midphase trials
Nick P.Taylor FIERCE PHARMA
14 Oct 2020
Share Share
Novartis dumps asthma program after another set of phase 3 flops

Novartis dumps asthma program after another set of phase 3 flops
Nick Paul Taylor FIERCE BIOTECH
16 Dec 2019
Share Share
Novartis` asthma drug fails in phase 3

Novartis` asthma drug fails in phase 3
Nick Paul Taylor FIERCE BIOTECH
22 Oct 2019
Share Share
Novartis CEO Vas Narasimhan lines up his late-stage blockbuster contenders

Novartis CEO Vas Narasimhan lines up his late-stage blockbuster contenders
John Carroll ENDPTS
06 Nov 2018
Share Share